Skip to main content
    T

    Tilray Inc (TLRY)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $2.34
    -0.09 (-3.70%)

    Market Cap: $359.12M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Tilray Inc (TLRY) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Tilray (TLRY) trades at 0.3x sales and 0.2x book value. Its forward P/E is 1000.0x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E1000.0x
    Price to sales0.3x
    Price to book0.2x
    PEGN/A
    FCF yield-38.1%
    As of Nov 17, 2026

    Valuation History

    Over the 3 of the 8 year ends shown that have a P/B, its P/B ranged from 0.3x in 2022 to 0.7x in 2021.

    Year endPriceP/SP/B
    2025$9.03N/AN/A
    2024$13.30N/AN/A
    2023$23.00N/A0.5x
    2022$26.902.4x0.3x
    2021$70.30N/A0.7x
    2020$82.60N/AN/A
    2019$171.30N/AN/A
    2018$705.40N/AN/A
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    Frequently Asked Questions About TLRY

    What is TLRY's forward P/E ratio?

    Tilray has a forward P/E ratio of 1000.0x.

    What is TLRY's price to sales ratio?

    Tilray has a price to sales ratio of 0.3x.